Androgen receptors are over overexpressed in only ~ 20% of NSCLC patients and were associated with more advanced disease (29), while androgen deprivation therapy has been reported to improve survival in NSCLC if started after diagnosis (10). This evidence concerns the gene AR and non-small cell lung carcinoma.